Profile picture of SWI swissinfo.ch
Turkey vs. Zolgensma: the battle over the world’s most expensive drug: Turkey and Novartis are in a stand-off over approval of Zolgensma - a $2 ...
swissinfo.ch/eng/multinational-companies/turkey-vs-novartis-the-battle-over-the-worlds-most-expensive-drug/76341423
Turkey vs. Zolgensma: the battle over the world’s most expensive drug
Profile picture of Financialexpress
USFDA gives nod to Novartis’ therapy for rare cancer among children: The study reported a safety profile consistent with the adult population studied in NETTER-1 ...
financialexpress.com/healthcare/pharma-healthcare/usfda-gives-nod-to-novartis-therapy-for-rare-cancer-among-children/3468162/
USFDA gives nod to Novartis’ therapy for rare cancer among children
Profile picture of Zofinger Tagblatt
Profile picture of SWI swissinfo.ch
Whatever happened to the world’s most expensive drug?: Zolgensma came to the market five years ago with a price tag of $2.1 million. What happened to it?
swissinfo.ch/eng/multinational-companies/whatever-happened-to-the-worlds-most-expensive-drug/75388576
Whatever happened to the world’s most expensive drug?
Profile picture of Reuters
Novartis begins tender offer for cancer-focused MorphoSys: Novartis said on Thursday it has launched a tender offer to acquire MorphoSys ...
reuters.com/business/healthcare-pharmaceuticals/novartis-begins-tender-offer-morphosys-2024-04-11/
Novartis begins tender offer for cancer-focused MorphoSys
Profile picture of Investor's Business Daily
Biotech Stocks Heat Up, Driven By A Spate Of Billion-Dollar Deals: Biotech stocks heated Thursday as Novartis scooped up a licensing pact with Arvinas and Janux ...
investors.com/news/technology/biotech-stocks-arvinas-novartis-licensing-deal-janux-takeover-interest/
Biotech Stocks Heat Up, Driven By A Spate Of Billion-Dollar Deals
Profile picture of Quartz
Moderna's new cancer vax, AstraZeneca CEO's big pay, and record-high drug shortages: Pharma news round up
qz.com/moderna-cancer-vax-astrazeneca-ceo-pay-drug-shortages-1851404812
Moderna's new cancer vax, AstraZeneca CEO's big pay, and record-high drug ...
Profile picture of Investor's Business Daily
How Novartis Rode Two Blockbusters To A Three-Day Sprint: Novartis stock jumped Tuesday after the drugmaker topped first-quarter sales and earnings forecasts ...
investors.com/news/technology/novartis-stock-novartis-earnings-q1-2024/
How Novartis Rode Two Blockbusters To A Three-Day Sprint
Quick Glance: Positive Quarterly Results Lead to Guidance Increase at Novartis
  • Novartis raises its annual guidance following a successful first quarter.

  • Revenue increased by 10% to $11.83 billion, with adjusted operating income growing by 16% to $4.54 billion.

  • CEO Vas Narasimhan is focusing more on drug development and has been active in mergers and acquisitions.

  • Novartis has secured promising drugs, including an experimental prostate cancer drug from Arvinas and the company MorphoSys, which develops cancer treatments, for 2.7 billion euros.
Profile picture of Quartz
AstraZenca is betting $2 billion on next-generation cancer treatments: AstraZeneca is acquiring Fusion Pharmaceuticals in a $2-billion deal
qz.com/astrazeneca-fusion-pharmaceuticals-2-billion-acquisitio-1851348307
AstraZenca is betting $2 billion on next-generation cancer treatments
Profile picture of Quartz
Moderna's new cancer vax, AstraZeneca CEO's big pay, and record-high drug shortages: Pharma news round up
qz.com/moderna-cancer-vax-astrazeneca-ceo-pay-drug-shortages-1851404812
Moderna's new cancer vax, AstraZeneca CEO's big pay, and record-high drug ...
Profile picture of DER AKTIONÄR
Apontis Pharma: Strong deal with Novartis - Share with price jump: Apontis Pharma cooperates with Novartis, raises forecast for 2024, shares rise by 10%.
deraktionaer.de/artikel/aktien/apontis-pharma-starker-deal-mit-novartis-aktie-mit-kurssprung-20354498.html
Apontis Pharma: Strong deal with Novartis - Share with price jump
Profile picture of Bloomberg
Novartis Seeks Malaria Patients in New Places as Climate Shifts: Malaria season should be over in Burkina Faso and Mali. This year, that’s not the case ...
bloomberg.com/news/articles/2024-04-04/novartis-seeks-malaria-patients-in-new-places-as-climate-shifts
Novartis Seeks Malaria Patients in New Places as Climate Shifts
Profile picture of PBS
Trials show asthma drug helps reduce allergic reactions to certain foods: There's some relief for people with food severe allergies. A study published in ...
pbs.org/newshour/show/trials-show-asthma-drug-helps-reduce-allergic-reactions-to-certain-foods
Trials show asthma drug helps reduce allergic reactions to certain foods
Profile picture of NPR
FDA approves a drug to treat severe food allergies, including milk, eggs and nuts
npr.org/2024/02/18/1232304606/fda-approval-food-allergies-xolair
FDA approves a drug to treat severe food allergies, including milk ...
Profile picture of ABC News
FDA expands use of asthma drug Xolair to treat severe food allergies: A medication used to treat asthma can now be used to help people with food allergies avoid ...
abcnews.go.com/Health/wireStory/fda-expands-asthma-drug-xolair-treat-severe-food-107297383
FDA expands use of asthma drug Xolair to treat severe food allergies
Profile picture of SWI swissinfo.ch
Novartis acquires German biotech MorphoSys for CHF2.5 billion: Even after its numerous acquisitions in 2023, the pharmaceutical company Novartis has not yet ...
swissinfo.ch/eng/business/novartis-acquires-german-biotech-morphosys-for-chf2_5-billion/49189882
Novartis acquires German biotech MorphoSys for CHF2.5 billion
Profile picture of medscape.com
FDA Approves Drug to Reduce Accidental Food Allergies: The new indication makes Xolair (omalizumab) the first drug approved to mitigate allergic reactions to ...
medscape.com/viewarticle/fda-approves-drug-reduce-accidental-food-allergies-2024a10003b3
FDA Approves Drug to Reduce Accidental Food Allergies
Profile picture of medscape.com
How to recognize WHF in patients with HFrEF and improve outcomes? 🖥️ Join as experts discuss GDMT and additional therapy to tackle these clinical issues ... Show more

ms.spr.ly/6182iL0pE
Profile picture of Sunderland Echo
Profile picture of NBC News
Man to spend life in prison for killing TikTok personality and his date at California movie theater
nbcnews.com/news/us-news/man-spend-life-prison-killing-tiktok-personality-date-california-movie-rcna140598
Man to spend life in prison for killing TikTok personality and his date at ...
Profile picture of Daily Mirror
Woman forced to make 120-mile round trip for lifeline drug for epilepsy: Hannah Hiles is one of many epilepsy sufferers experiencing a shortage of drugs such as ...
mirror.co.uk/news/uk-news/woman-forced-make-120-mile-32231415
Woman forced to make 120-mile round trip for lifeline drug for epilepsy
Profile picture of The Seattle Times
Drug drastically reduces children’s reactions to traces of food allergens: A drug that has been used for decades to treat allergic asthma and hives significantly ...
nytimes.com/2024/02/25/health/children-food-allergies-xolair.html
Drug drastically reduces children’s reactions to traces of food allergens
Profile picture of The Times
Asthma drug slashes risk of fatal food allergies: Xolair, a 20-year-old asthma medication, reduces dangerous reactions to foods including peanuts and eggs — but ...
thetimes.co.uk/article/asthma-drug-xolair-fatal-food-allergies-risk-6svs2rzr8
Asthma drug slashes risk of fatal food allergies
Profile picture of Dailynewsegypt
Egypt’s Health Ministry, Novartis sign protocol to modernise cardiac catheterisation system - Dailynewsegypt
dailynewsegypt.com/2024/02/26/egypts-health-ministry-novartis-sign-protocol-to-modernise-cardiac-catheterisation-system/
Egypt’s Health Ministry, Novartis sign protocol to modernise cardiac ...
Profile picture of WTVF
Did you know about 6% of the U.S. population has a food allergy, according to the CDC? The FDA has approved two first-of-its-kind treatments — one for severe ... Show more

FDA expands use of asthma drug Xolair to treat severe food allergies

FDA announces approval for first severe frostbite treatment
Profile picture of medscape.com
Facing the Challenges: Expert Perspectives on Managing Worsening Heart Failure: How to recognize WHF in patients with HFrEF and improve outcomes? Join as experts ...
ms.spr.ly/6182iL0HK
Facing the Challenges: Expert Perspectives on Managing Worsening Heart ...
Profile picture of SWI swissinfo.ch
Novartis makes progress with myeloid leukaemia drug: Swiss pharma Novartis sees clinical trial superiority of Scemblix for Philadelphia chromosome-positive ...
swissinfo.ch/eng/sci-tech/novartis-makes-progress-with-myeloid-leukaemia-drug/49109142
Novartis makes progress with myeloid leukaemia drug
Profile picture of Investor's Business Daily
This Biotech Just Catapulted 33%, Flashing A Bullish Sign: Novartis expanded its gene therapy collaboration with Voyager on Tuesday, and VYGR stock rocketed ...
investors.com/news/technology/vygr-stock-catapults-higher-after-novartis-sweetens-its-gene-therapy-deal/
This Biotech Just Catapulted 33%, Flashing A Bullish Sign
Profile picture of Forbes
FDA Approves First Medication For Treating Allergic Reactions To Multiple Foods: The injectable drug is not approved for “immediate emergency treatment of ...
forbes.com/sites/caileygleeson/2024/02/16/fda-approves-first-medication-for-treating-allergic-reactions-to-multiple-foods/
FDA Approves First Medication For Treating Allergic Reactions To Multiple ...
Profile picture of Financialexpress
Sandoz launches biosimilar for multiple sclerosis in Germany: In 2019, Sandoz entered into a global commercialization agreement for biosimilar natalizumab with ...
financialexpress.com/healthcare/pharma-healthcare/sandoz-launches-biosimilar-for-multiple-sclerosis-in-germany/3379753/
Sandoz launches biosimilar for multiple sclerosis in Germany
Profile picture of Bloomberg
Novartis Sees Strong Profit Growth Amid Demand For New Drugs: Novartis AG forecast earnings will grow at a high single digit pace this year as the Swiss ...
bloomberg.com/news/articles/2024-01-31/novartis-sees-strong-profit-growth-amid-demand-for-new-drugs
Novartis Sees Strong Profit Growth Amid Demand For New Drugs
Profile picture of Neue Zürcher Zeitung
Popular weight loss injections: Eli Lilly and Novo Nordisk are chasing records: Investors expect record-high sales from new therapies to treat obesity. However ...
nzz.ch/wirtschaft/beliebte-abnehmspritzen-eli-lilly-und-novo-nordisk-jagen-rekorde-ld.1773336
Popular weight loss injections: Eli Lilly and Novo Nordisk are chasing ...
Profile picture of CNBC
If you can't build the next Ozempic, buy it: Where M&A could be heading in the obesity drug space
cnbc.com/2023/12/13/where-ma-could-be-heading-in-the-obesity-drug-space.html
If you can't build the next Ozempic, buy it: Where M&A could be heading in ...
Profile picture of The Hill (newspaper)
New treatment for food allergies in kids moves closer to finish line: An existing asthma treatment shows promise for reducing food allergies in children and is ...
thehill.com/policy/healthcare/4379190-new-treatment-food-allergies-fda/
New treatment for food allergies in kids moves closer to finish line
Profile picture of Neue Zürcher Zeitung
With Ritalin against ADHD: where children take the most medication: In the canton of Neuchâtel, children receive twice as many ADHD medications as in the rest of ...
nzz.ch/schweiz/neuenburg-ist-ritalin-spitzenreiter-der-schweiz-ld.1761386
With Ritalin against ADHD: where children take the most medication
Profile picture of BBC News
Bradley Lowery: Sheffield Wednesday fan sentenced over photo jibe: Dale Houghton is given a 12-week suspended jail term for mocking the young Sunderland fan's ...
bbc.com/news/uk-england-south-yorkshire-67444742
Bradley Lowery: Sheffield Wednesday fan sentenced over photo jibe
Profile picture of Der Bund
Treatment of ADHD: And Ritalin is always irritating: A member of the federal expert group compares the use of the widely used ADHD medication with “corporal ...
tagesanzeiger.ch/behandlung-von-adhs-und-immer-reizt-das-ritalin-718823017929
Treatment of ADHD: And Ritalin is always irritating
Profile picture of The Star (Malaysia)
Charity run in Shah Alam to support SMA patients: THE Spinal Muscular Atrophy Malaysia (SMAM) had its inaugural charity fun run with the theme “Together we care” ...
thestar.com.my/metro/metro-news/2023/12/16/charity-run-in-shah-alam-to-support-sma-patients
Charity run in Shah Alam to support SMA patients
Profile picture of Marie Claire
“For the 30% who have their cancer metastasize, far too many often discover it too late. That awareness needs to change” This disease awareness material has ... Show more
Profile picture of The Orange County Register
Corona theater shooter claims voices prompted him to kill 2 teens: Joseph Jimenez testified Monday in his insanity trial that will send him either to prison or a ...
pressenterprise.com/2023/12/04/corona-theater-shooter-claims-voices-prompted-him-to-kill-2-teens/
Corona theater shooter claims voices prompted him to kill 2 teens
Profile picture of Marie Claire
Meet remarkable women living with breast cancer and hear their stories on making moments count. This disease awareness material has been funded by Novartis ... Show more
Profile picture of Die Zeit
Eckart von Hirschhausen on ADHD: "I've had suspicions for a long time": Eckart von Hirschhausen made a film about ADHD. In it he also reveals his own diagnosis ...
zeit.de/gesundheit/2023-10/eckart-von-hirschhausen-adhs-dokumentation
Eckart von Hirschhausen on ADHD:
Profile picture of Frankfurter Allgemeine Zeitung
Homeopathy for ADHD: Globules cannot replace Ritalin after all: According to a study by German researchers, homeopathic remedies could replace Ritalin - but it ...
faz.net/aktuell/wissen/medizin-ernaehrung/homoeopathie-bei-adhs-globuli-doch-kein-ersatz-fuer-ritalin-19290179.html
Homeopathy for ADHD: Globules cannot replace Ritalin after all
Profile picture of Marie Claire
“You’ve still got to put your feet on the floor and walk forward” Four women get frank about the realities of living with breast cancerThis disease ... Show more
Profile picture of Sky News
Bradley Lowery: Man pleads guilty to public order offence after mocking death of six-year-old football mascot
news.sky.com/story/bradley-lowery-man-pleads-guilty-to-public-order-offence-after-mocking-death-of-six-year-old-football-mascot-12974786
Bradley Lowery: Man pleads guilty to public order offence after mocking ...
Quick Glance: Man convicted for mocking deceased football mascot
  • A 31-year-old man has been convicted for mocking the death of football mascot Bradley Lowery at a match.

  • A participant held up an image of Bradley, who passed away at the age of six due to neuroblastoma.

  • A statement was read out in court by Gemma Lowery, Bradley's mother.

  • Following the incident, over £11,000 has been raised for The Bradley Lowery Foundation, a charity established after the boy's death.
Profile picture of Luzerner Zeitung
Drug abuse in Switzerland - the offer: Adolescents and young adults obtain powerful medications via social networks - and abuse them to get drunk ...
luzernerzeitung.ch/leben/medikamentenmissbrauch-im-angebot-ritalin-xanax-hustensaft-jugendliche-bestellen-medikamente-vom-schwarzmarkt-fast-so-einfach-wie-pizza-ld.2507412
Drug abuse in Switzerland - the offer
Profile picture of Marie Claire
No two women’s experience of breast cancer is the same. This disease awareness material has been funded by Novartis Pharmaceutical UK Limited (Novartis) and ... Show more
Profile picture of inFranken.de
New treatment for ADHD without Ritalin: Every day, children diagnosed with ADHD face the challenges of hyperactivity, impulsivity and inattention in their school ...
infranken.de/ratgeber/pi/neue-behandlung-bei-adhs-ohne-ritalin-art-5676190
New treatment for ADHD without Ritalin
Profile picture of Der Tagesspiegel
As enthusiastically as Gert Dorschner talks about trampoline jumping, you might think that he is still a child himself. But Dorschner is 58 years old and he is ... Show more

bitly.ws/ZnZf
Profile picture of Euractiv
Patient access to Slovak market’s most expensive drug remains blurry: In Slovakia, a dispute has resurfaced over who should foot the bill for highly expensive ...
euractiv.com/section/health-consumers/news/patient-access-to-slovak-markets-most-expensive-drug-remains-blurry/
Patient access to Slovak market’s most expensive drug remains blurry
Profile picture of Bloomberg
Novartis (NOVN) Weighs Selling Assets from Radiopharma Unit AAA: Novartis AG is considering selling part of radiopharmaceuticals company Advanced Accelerator ...
bloomberg.com/news/articles/2023-10-03/novartis-is-said-to-weigh-selling-assets-from-radiopharma-unit
Novartis (NOVN) Weighs Selling Assets from Radiopharma Unit AAA
Profile picture of Zofinger Tagblatt
Profile picture of Metro (British newspaper)
A 31-year-old man has pleaded guilty to a public order offence after mocking the death of young cancer victim Bradley Lowery ... Show more
Profile picture of Der Tagesspiegel
hen she was told that it would not work without tablets. Complaints from the teachers kept coming. Stefanie F. received her son's ADHD diagnosis when he ... Show more

bitly.ws/VBhx